---
title: "Imax Analysts Boost Their Forecasts After Better-Than-Expected Q2 Earnings"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293764517.md"
description: "IMAX Corp. reported strong Q2 earnings, beating estimates with $0.43 EPS and $102.8M revenue. Analysts raised price targets, citing a robust film slate including 'The Odyssey' and upcoming titles. Shares rose 1.1% in pre-market trading following the positive results and upgraded forecasts."
datetime: "2026-07-24T13:16:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293764517.md)
  - [en](https://longbridge.com/en/news/293764517.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293764517.md)
---

# Imax Analysts Boost Their Forecasts After Better-Than-Expected Q2 Earnings

**IMAX Corp.** (NYSE:IMAX) on Thursday reported upbeat second-quarter results.

The company posted adjusted earnings of 43 cents per share, beating the analyst consensus estimate of 28 cents, according to Benzinga Pro. That was up from 26 cents per share a year earlier. Revenue increased to $102.8 million from $91.7 million a year ago, exceeding analysts’ estimate of $93.7 million.

Looking ahead, IMAX expects a strong second-half film slate, including Dune: Part Three, Spider-Man: Brand New Day in China, Japan and South Korea, Tom Cruise’s Digger, and the exclusive theatrical release of Netflix’s Cliff Booth project.

“As we enter the second half of 2026, Christopher Nolan’s breathtaking The Odyssey — the first-ever full-length theatrical release filmed entirely with IMAX film cameras — is emerging as a transformational event for IMAX, as the purest and most complete expression yet of the power of our global platform,” said Rich Gelfond, CEO of IMAX. “In its debut, The Odyssey achieved the biggest IMAX opening weekend of all time in like-for-like markets(1) and delivered the highest IMAX international market share in like-for-like markets of any major release in our history.”

IMAX shares rose 1.1% to $44.43 in pre-market trading.

These analysts made changes to their price targets on IMAX following earnings announcement.

-   Wedbush analyst Alicia Reese maintained the stock with an Outperform rating and raised the price target from $46 to $54.
-   Rosenblatt analyst Steve Frankel maintained the stock with a Buy and raised the price target from $47 to $50.

**Considering buying IMAX stock? Here’s what analysts think:**

_Photo via Shutterstock_

### Related Stocks

- [IMAX.US](https://longbridge.com/en/quote/IMAX.US.md)
- [NFLX.US](https://longbridge.com/en/quote/NFLX.US.md)
- [SSTK.US](https://longbridge.com/en/quote/SSTK.US.md)

## Related News & Research

- [Why IMAX stock popped today](https://longbridge.com/en/news/293669705.md)
- [What fueled the 'The Odyssey' box office frenzy? IMAX CEO speaks out](https://longbridge.com/en/news/293391810.md)
- [Short Squeeze And Earnings: Why IMAX Stock Spiked Thursday](https://longbridge.com/en/news/293631514.md)
- [Imax's CEO says it's time to hike prices as tickets to 'The Odyssey' resell for $1,000](https://longbridge.com/en/news/293659241.md)
- [IMAX: Record Q2 growth driven by The Odyssey, strong margins, and expanding global IMAX network](https://longbridge.com/en/news/293639681.md)